购物车
- 全部删除
- 您的购物车当前为空
PDE4-IN-13 is a phosphodiesterase 4 inhibitor with an IC50 value of 1.56 μM, exhibiting anti-inflammatory and antioxidative properties. It is utilized in the study of chronic obstructive pulmonary disease (COPD).
PDE4-IN-13 is a phosphodiesterase 4 inhibitor with an IC50 value of 1.56 μM, exhibiting anti-inflammatory and antioxidative properties. It is utilized in the study of chronic obstructive pulmonary disease (COPD).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic obstructive pulmonary disease (COPD) [1]. |
靶点活性 | PDE4:1.56 μM |
体外活性 | PDE4-IN-13(化合物6o)能显著抑制RAW264.7巨噬细胞内由LPS诱导的TNF-α产出,并降低小鼠肺组织匀浆中Fe 2+诱发的MDA生成。此外,PDE4-IN-13在还原Fe 3+以及络合Fe 2+方面也表现出卓越的效果[1]。 |
体内活性 | PDE4-IN-13(化合物 6o)以50 mg/kg和100 mg/kg剂量腹膜内注射,能显著抑制LPS引发的小鼠血清中TNF-α的升高[1]。 |
分子量 | 340.37 |
分子式 | C20H20O5 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容